Compounds > levodopa
Page last updated: 2024-08-17

levodopa and Body Weight

levodopa has been researched along with Body Weight in 83 studies

Research

Studies (83)

TimeframeStudies, this research(%)All Research%
pre-199031 (37.35)18.7374
1990's16 (19.28)18.2507
2000's18 (21.69)29.6817
2010's13 (15.66)24.3611
2020's5 (6.02)2.80

Authors

AuthorsStudies
Balogun, CI; Fatoki, AM; Oladimeji, S; Olofinnade, AT; Onaolapo, AY; Onaolapo, OJ; Onaolapo, TM1
Chang, Y; Li, Y; Liu, X; Wang, L; Yan, Y; Zhang, L1
Aragão Catunda Junior, FE; Basto Souza, R; da Cunha Ferreira, NM; de Sousa Dos Reis, TD; Hardy Lima Pontes, N; Maranguape Silva da Cunha, R; Moreira Vasconcelos, CF; Vasconcelos Aguiar, LM1
Baik, K; Chung, SJ; Hong, JM; Jung, JH; Kim, YJ; Lee, HS; Lee, PH; Lee, YH; Sohn, YH; Yoo, HS1
Khurana, N; Muthuraman, A; Sharma, N; Utreja, P1
Hu, LF; Li, SY; Liu, CF; Liu, WW; Lyu, DJ; Mao, CJ; Wang, F; Wang, YL; Yang, YP1
Aung, MH; Iuvone, PM; Kim, MK; Mees, L; Olson, DE; Pardue, MT; Pozdeyev, N; Thule, PM1
Goschke, T; Kienast, A; Lee, Y; London, ED; Petzold, J; Pooseh, S; Smolka, MN1
Chaturvedi, CM; Singh, VP1
Artuch-Iriberri, R; de la Caridad, O; Esteller, M; Fourcade, S; Huertas, D; Molero-Luis, M; Petazzi, P; Pujol, A; Roa, L; Saez, MA; Soler, M; Szczesna, K; Vidal, A1
Sharma, JC; Vassallo, M1
Chew, B; Dayan, P; Dolan, RJ; Ousdal, OT; Rigoli, F; Rutledge, RB1
Armand, S; Burkhard, PR; Landis, T; Sztajzel, R1
Bachmann, CG; Brunner, E; Trenkwalder, C; Zapf, A1
Galna, B; Morris, ME; Murphy, AT1
Darvas, M; Palmiter, RD1
Gray, WK; Howells, AR; Walker, RW1
Chaturvedi, CM; Sethi, S1
Guertin, PA; Rouleau, P; Ung, RV1
Bunzeck, N; Dolan, RJ; Duzel, E; Guitart-Masip, M1
Dass, B; Engber, TM; Galdes, A; Iravani, MM; Jackson, MJ; Jenner, P1
Froelick, GJ; Kim, DS; Palmiter, RD1
Quattrone, A; Zappia, M1
Kim, DS; Palmiter, RD1
Arabia, G; Bagalà, A; Bastone, L; Bosco, D; Caracciolo, M; Crescibene, L; Quattrone, A; Scornaienghi, M; Zappia, M1
Berenguer, P; Pequignot, JM; Perrin, D; Soulage, C1
Barnes, KM; Baron, J; Coco, M; Jones, J; Nwosu, BU; Yanovski, JA1
Bérod, A; Dalmaz, Y; Mamet, J; Perrin, D; Roux, JC; Scarna, H1
Ross, IN; Sharma, JC; Vassallo, M1
Aa Sunde, N; Østergaard, K1
He, QJ; Xu, SQ1
Barker, RA; Kuan, WL; Zhao, JW1
Brooks, D; Rascol, O; Ross, IN; Sharma, JC1
Dikshit, RK; Doctor, RB; Gandhi, IC; Shah, UH; Vajpeyee, S1
Agras, WS; Kraemer, HC1
Armstrong, D; Courtney, CL; Palfai, T1
Cooper, DR; Fleminger, S; Hall, MD; Jenner, P; Marsden, CD; Rupniak, NM1
Benderly, A; Greif, Z; Hochberg, Z; Levy, J1
Gerdes, U; Lehmann, K; Ulm, G1
Kemi, M; Kondo, M; Maki, E; Tanabe, K1
Graczykowska-Koczorowska, A; Ponikowska, I1
Harell, A; Hoerer, E; Laurian, L; Oberman, Z; Wiznitzer, T1
Battistin, L; Bettineschi, F; Dussini, N; Rigotti, P; Vassanelli, P; Zanchin, G1
Callingham, BA; Lyles, GA1
Bhawan, J; Carlson, KR; DeGirolami, U; Sahakian, BJ1
Hosokawa, S; Matsuo, M; Murakami, M; Nakamura, J; Okuno, Y; Yamada, H; Yamada, T1
Jenner, P; Marsden, CD; Rose, S1
Gash, DM; Sakai, K1
Miyagawa, I; Sofikitis, N; Yamamoto, Y1
Sakajiri, K; Takamori, M1
Liang, YX; Zheng, YX1
Bruguerolle, B; Mouchet, J; Simon, N1
Cannizzaro, C; Costa, S; Iravani, MM; Jackson, MJ; Jenner, P; Pearce, RK; Tel, BC1
Müller, T1
Gotoh, Y; Hiraishi, K; Kawamura, K; Kobayashi, M; Sano, H1
Creese, I; Iversen, SD1
Harvey, JA; Schlosberg, AJ1
Barbieri, S; Bevilacqua, M; Lanfredini, M; Micossi, P; Nitti, F; Norbiato, G; Raggi, U1
Matsuzawa, T1
Bischoff, F; Bryson, G1
Bosch Millares, C; Cardenal del Valle, C; Rodríguez Doreste, OL1
Lyles, GA1
Ayalon, D; Herzberg, M; Oberman, Z; Rabey, I; Streifler, M; Vardi, J1
Cotzias, GC; Miller, ST; Papavasiliou, PS; Tang, LC1
Annau, Z; Fechter, LD1
Nygren, LG; Olson, L1
Gasparini, M; Spinnler, H1
Chaturvedi, CM; Prasad, SK; Thapliyal, JP1
Kaiser, R; Ziegler, G1
Barr, SI; Paré, S; Ross, SE1
Frindik, JP; Hale, B; Kearns, FS; Kemp, SF1
Drucker-Colín, R; García-Hernández, F1
Blunt, S; Jenner, P; Marsden, CD1
Hayashi, M; Kitajima, W; Saruta, T; Yamaji, Y1
Brown, JW; Freeman, GB; Ieni, JR; Soblosky, JS; Thurmond, JB1
Inoue, S; Nakamura, S; Numata, K; Okazaki, H; Takamura, Y; Tanaka, K1
Archer, T; Fredriksson, A; Sundström, E1
Bieglmayr, C; Frisch, H; Schober, E; Waldhauser, F1
Lang, AE; Riley, D1
Buu, NT; Duhaime, J; Kuchel, O; Racz, K; Schlager, G1
Grzywa, M1
Kelley, AE; Stinus, L1
Johanson, AJ; Knorr, NJ1

Reviews

2 review(s) available for levodopa and Body Weight

ArticleYear
Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype.
    Neurodegenerative disease management, 2014, Volume: 4, Issue:4

    Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Energy Intake; Female; Humans; Levodopa; Male; Nutritional Status; Parkinson Disease; Quality of Life; Sex Factors; Smell; Thinness; Treatment Outcome; Weight Loss

2014
Non-dopaminergic drug treatment of Parkinson's disease.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4

    Topics: Adenosine; Adrenergic alpha-Antagonists; Body Weight; Cholinergic Antagonists; Homocysteine; Humans; Levodopa; Methionine; N-Methylaspartate; Parkinson Disease; Piperidines; Serotonin Receptor Agonists

2001

Trials

2 trial(s) available for levodopa and Body Weight

ArticleYear
Dopamine Increases a Value-Independent Gambling Propensity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:11

    Topics: Adult; Body Weight; Choice Behavior; Computer Simulation; Dopamine Agents; Double-Blind Method; Female; Gambling; Games, Experimental; Healthy Volunteers; Humans; Levodopa; Male; Models, Psychological; Risk-Taking; Surveys and Questionnaires; Time Factors; Young Adult

2016
The treatment of anorexia nervosa: do different treatments have different outcomes?
    Research publications - Association for Research in Nervous and Mental Disease, 1984, Volume: 62

    Topics: Adolescent; Amitriptyline; Anorexia Nervosa; Behavior Therapy; Body Weight; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Female; Humans; Insulin; Levodopa; Lithium; Lithium Carbonate; Prognosis

1984

Other Studies

79 other study(ies) available for levodopa and Body Weight

ArticleYear
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice.
    Central nervous system agents in medicinal chemistry, 2020, Volume: 20, Issue:1

    Topics: Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Body Weight; Carbidopa; Chlorpromazine; Diet; Drug Combinations; Eating; Grooming; Levodopa; Lipid Peroxidation; Mice; Motor Activity; Parkinson Disease, Secondary; Pyridoxal Phosphate

2020
Analysis of factors associated with brittle response in patients with Parkinson's disease.
    Annals of clinical and translational neurology, 2020, Volume: 7, Issue:5

    Topics: Adult; Body Mass Index; Body Weight; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Risk Factors; Sex Factors; Time Factors

2020
Eugenol and its association with levodopa in 6-hydroxydopamine-induced hemiparkinsonian rats: Behavioural and neurochemical alterations.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:4

    Topics: Animals; Behavior, Animal; Body Weight; Brain; Disease Models, Animal; Eugenol; Glutathione; Levodopa; Lipid Peroxidation; Male; Motor Activity; Neuroprotective Agents; Nitrites; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar

2020
Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson's Disease.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2021, 11-15, Volume: 76, Issue:12

    Topics: Antiparkinson Agents; Body Weight; Dyskinesias; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle, Skeletal; Parkinson Disease; Sarcopenia

2021
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model.
    European journal of pharmacology, 2021, Jul-15, Volume: 903

    Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid

2021
Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease.
    Chinese medical journal, 2017, May-05, Volume: 130, Issue:9

    Topics: Animals; Blotting, Western; Body Weight; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Levodopa; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction

2017
Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
    Investigative ophthalmology & visual science, 2018, 01-01, Volume: 59, Issue:1

    Topics: Animals; Blood Glucose; Body Weight; Dark Adaptation; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dopamine; Dopamine Agents; Electroretinography; Female; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oscillometry; Retinal Rod Photoreceptor Cells; Tyrosine 3-Monooxygenase

2018
Baseline impulsivity may moderate L-DOPA effects on value-based decision-making.
    Scientific reports, 2019, 04-04, Volume: 9, Issue:1

    Topics: Adult; Body Weight; Brain; Choice Behavior; Cross-Over Studies; Decision Making; Delay Discounting; Dopamine; Dopamine Agents; Double-Blind Method; Female; Humans; Impulsive Behavior; Levodopa; Male; Prefrontal Cortex; Random Allocation; Reward

2019
Interrelationship between NO and androgenic activity in mice, Mus musculus, following temporal phase relation of serotonergic and dopaminergic neural oscillations.
    Endocrine, 2014, Volume: 46, Issue:3

    Topics: 5-Hydroxytryptophan; Age Factors; Animals; Body Weight; Dopamine; Levodopa; Male; Mice; Nitric Oxide; Serotonin; Testis; Testosterone

2014
Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:12

    Topics: Animals; Anti-Dyskinesia Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Body Weight; Brain; Cell Enlargement; Dendrites; Disease Models, Animal; Dopa Decarboxylase; Dopaminergic Neurons; Levodopa; Male; Methyl-CpG-Binding Protein 2; Mice, Inbred C57BL; Mice, Knockout; Movement; Phenotype; Respiration; Rett Syndrome

2014
Dyskinesia-induced postural instability in Parkinson's disease.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:5

    Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Body Weight; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Postural Balance; Posture

2009
Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
    European journal of neurology, 2009, Volume: 16, Issue:8

    Topics: Age of Onset; Aged; Antiparkinson Agents; Body Mass Index; Body Weight; Dopamine Agents; Dyskinesias; Eating; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Severity of Illness Index; Time Factors; Weight Loss

2009
Obstacle crossing in people with Parkinson's disease: foot clearance and spatiotemporal deficits.
    Human movement science, 2010, Volume: 29, Issue:5

    Topics: Acclimatization; Adaptation, Physiological; Aged; Antiparkinson Agents; Body Height; Body Weight; Female; Foot; Gait; Humans; Levodopa; Locomotion; Male; Parkinson Disease; Postural Balance; Posture; Psychomotor Performance; Reference Values; Walking

2010
Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-20, Volume: 30, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Body Weight; Cognition; Conditioning, Operant; Corpus Striatum; Discrimination Learning; Dopamine; Dopamine Agents; Exploratory Behavior; Feeding Behavior; Female; Gene Expression Regulation; Gene Transfer Techniques; Homovanillic Acid; Levodopa; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neuropsychological Tests; Recognition, Psychology; Signal Transduction; Tyrosine 3-Monooxygenase

2010
The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Weight; Dose-Response Relationship, Drug; Dyskinesias; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Prognosis

2011
Temporal phase relation of circadian neural oscillations as the basis of testicular maturation in mice: a test of a coincidence model.
    Journal of biosciences, 2010, Volume: 35, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Body Weight; Circadian Rhythm; Fructose; Levodopa; Male; Mice; Neurosecretory Systems; Seminiferous Tubules; Sperm Count; Sperm Motility; Testis; Testosterone; Time Factors

2010
Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice.
    Neurorehabilitation and neural repair, 2012, Volume: 26, Issue:4

    Topics: Adipose Tissue; Analysis of Variance; Animals; Biomechanical Phenomena; Body Composition; Body Weight; Bone Density; Buspirone; Densitometry; Disease Models, Animal; Dopamine Agents; Exercise Test; Exercise Therapy; Histocompatibility Antigens; Levodopa; Male; Mice; Motor Activity; Muscle Fibers, Skeletal; Muscle, Skeletal; Paraplegia; Recovery of Function; Sacrococcygeal Region; Serotonin Receptor Agonists; Spinal Cord Injuries

2012
Pharmacological dissociation of novelty responses in the human brain.
    Cerebral cortex (New York, N.Y. : 1991), 2014, Volume: 24, Issue:5

    Topics: Attention; Body Weight; Brain; Brain Mapping; Cholinesterase Inhibitors; Dopamine Agents; Exploratory Behavior; Female; Galantamine; Healthy Volunteers; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neural Pathways; Photic Stimulation; Reaction Time; Recognition, Psychology; Repression, Psychology; Young Adult

2014
Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
    Neuroscience, 2002, Volume: 114, Issue:1

    Topics: Animals; Behavior, Animal; Body Weight; Callithrix; Cell Count; Dopamine; Drug Interactions; Female; Glial Fibrillary Acidic Protein; Hedgehog Proteins; Immunohistochemistry; Levodopa; Male; Motor Activity; Nerve Growth Factors; Nerve Regeneration; Neurons; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Trans-Activators; Treatment Outcome; Tyrosine 3-Monooxygenase

2002
Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Nov-15, Volume: 22, Issue:22

    Topics: Aging; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Body Weight; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Immunohistochemistry; Levodopa; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurons; Proto-Oncogene Proteins c-fos; Receptors, Dopamine D1; Receptors, Opioid, mu; Signal Transduction; Sodium Chloride

2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
    Neurology, 2002, Dec-24, Volume: 59, Issue:12

    Topics: Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Body Weight; Drug Interactions; Female; Humans; Levodopa; Male; Pramipexole; Sex Characteristics; Thiazoles

2002
Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, Feb-04, Volume: 100, Issue:3

    Topics: Amygdala; Animals; Body Weight; Brain; Caffeine; Central Nervous System Stimulants; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Genotype; Hypothalamus; Immunohistochemistry; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Proto-Oncogene Proteins c-fos; Receptors, Purinergic P1; Signal Transduction; Time Factors

2003
Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2

    Topics: Administration, Oral; Aged; Body Weight; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors

2002
Sub-chronic exposure to toluene at 40 ppm alters the monoamine biosynthesis rate in discrete brain areas.
    Toxicology, 2004, Mar-01, Volume: 196, Issue:1-2

    Topics: 5-Hydroxytryptophan; Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Cerebellum; Female; Levodopa; Male; Organ Size; Prosencephalon; Rats; Rats, Sprague-Dawley; Toluene; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase

2004
Short stature with normal growth hormone stimulation testing: lack of evidence for partial growth hormone deficiency or insensitivity.
    Hormone research, 2004, Volume: 62, Issue:2

    Topics: Adolescent; Adrenergic alpha-Agonists; Arginine; Body Weight; Child; Clonidine; Dwarfism, Pituitary; Female; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Retrospective Studies

2004
Long-term prenatal hypoxia alters maturation of brain catecholaminergic systems and motor behavior in rats.
    Synapse (New York, N.Y.), 2004, Volume: 54, Issue:2

    Topics: Age Factors; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Catecholamines; Enzyme Inhibitors; Exploratory Behavior; Female; Hydrazines; Hypoxia; Levodopa; Male; Motor Activity; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Time; Time Factors; Tyrosine 3-Monooxygenase

2004
Current controversies: levodopa in the treatment of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies

2005
Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:5

    Topics: Activities of Daily Living; Adult; Aged; Analysis of Variance; Antiparkinson Agents; Body Weight; Deep Brain Stimulation; Disease Progression; Dyskinesias; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome

2006
[Effects of Maidang Rutong granule on l-dopa-induced galactozemia in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2007, Volume: 32, Issue:8

    Topics: Animals; Animals, Newborn; Atrophy; Body Weight; Drug Combinations; Drugs, Chinese Herbal; Female; Lactation; Lactation Disorders; Levodopa; Male; Mammary Glands, Animal; Prolactin; Random Allocation; Rats; Rats, Sprague-Dawley

2007
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
    Psychopharmacology, 2008, Volume: 197, Issue:2

    Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nervous System Stimulants; Citalopram; Dopamine Agents; Drinking; Dyskinesia, Drug-Induced; Image Processing, Computer-Assisted; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Sympatholytics; Synaptic Transmission

2008
Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight.
    European journal of neurology, 2008, Volume: 15, Issue:5

    Topics: Age Factors; Aged; Antiparkinson Agents; Body Size; Body Weight; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease

2008
Possible role of dopamine in the growth inhibitory effect of pentazocine.
    Developmental pharmacology and therapeutics, 1983, Volume: 6, Issue:2

    Topics: Animals; Body Weight; Dopamine; Dopamine Antagonists; Drug Synergism; Growth; Levodopa; Metoclopramide; Pentazocine; Rats; Rats, Inbred Strains; Receptors, Opioid

1983
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
    Physiology & behavior, 1984, Volume: 33, Issue:2

    Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors

1984
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Neuropharmacology, 1984, Volume: 23, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Body Weight; Brain Chemistry; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Levodopa; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior

1984
Growth enhancement induced by prolonged L-dopa administration in rats.
    Biochemical medicine, 1983, Volume: 30, Issue:1

    Topics: Animals; Body Height; Body Weight; Female; Growth; Growth Hormone; Kidney; Levodopa; Male; Organ Size; Rats; Rats, Inbred Strains; Thymus Gland

1983
Response to Sinemet 25/100 in Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Aged; Benserazide; Body Weight; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors

1984
Influence of carbidopa, an aromatic amino acid decarboxylase inhibitor, on the development of autoimmune hemolytic anemia in NZB mice.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:2

    Topics: Anemia, Hemolytic, Autoimmune; Animals; Body Weight; Carbidopa; Coombs Test; Female; Hematocrit; Levodopa; Male; Methyldopa; Mice; Mice, Inbred NZB

1983
[Blood serum growth hormone and insulin concentration in persons with normal body weight, obese patients without carbohydrate intolerance and obese diabetics after L-dopa loading test].
    Polskie Archiwum Medycyny Wewnetrznej, 1980, Volume: 64, Issue:5

    Topics: Adult; Body Weight; Diabetes Mellitus; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity

1980
Growth hormone response to L-dopa in the thinned obese.
    Israel journal of medical sciences, 1982, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Body Weight; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Obesity

1982
Effect of L-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis.
    Neurochemical research, 1981, Volume: 6, Issue:6

    Topics: Amino Acids; Animals; Body Weight; Brain; Cerebellum; Levodopa; Male; Medulla Oblongata; Portacaval Shunt, Surgical; Rats; Rats, Inbred Strains; Time Factors

1981
Short- and long-term effects of L-DOPA treatment upon monoamine oxidase: a comparative study in several rat tissues.
    European journal of pharmacology, 1980, Volume: 61, Issue:4

    Topics: Animals; Aorta; Body Weight; Brain; Kidney; Levodopa; Liver; Male; Monoamine Oxidase; Myocardium; Organ Size; Rats; Time Factors

1980
Functional and structural consequences of long-term dietary L-dopa treatment in mice.
    Communications in psychopharmacology, 1980, Volume: 4, Issue:2

    Topics: Animals; Body Weight; Brain; Diet; Levodopa; Male; Mice; Motor Activity; Receptors, Dopamine

1980
Effect of chronic L-dopa administration on serum luteinizing hormone levels in male rats.
    Toxicology, 1995, Mar-31, Volume: 97, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Hypothalamus; Levodopa; Luteinizing Hormone; Male; Organ Size; Prolactin; Rats; Rats, Wistar

1995
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
    The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:8

    Topics: Administration, Oral; Animals; Body Weight; Carbidopa; Dopa Decarboxylase; Drug Administration Schedule; Injections, Intra-Arterial; Levodopa; Liver; Male; Rats; Rats, Wistar; Time Factors

1993
Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.
    Brain research, 1994, Jan-07, Volume: 633, Issue:1-2

    Topics: Amphetamine; Animals; Apomorphine; Body Weight; Immunohistochemistry; Levodopa; Male; Motor Activity; Nerve Fibers; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Substantia Nigra; Tyrosine 3-Monooxygenase

1994
Effects of chronic renal failure on hypothalamo-pituitary-testicular axis function and fertility in rats.
    International journal of urology : official journal of the Japanese Urological Association, 1996, Volume: 3, Issue:6

    Topics: Androgen-Binding Protein; Animals; Body Weight; Creatinine; Cytosol; Dopamine Agents; Epididymis; Fertility; Hyperprolactinemia; Hypothalamo-Hypophyseal System; Kidney Failure, Chronic; Levodopa; Leydig Cells; Male; Nephrectomy; Organ Size; Prolactin; Rats; Rats, Wistar; Sertoli Cells; Sperm Motility; Spermatogenesis; Spermatozoa; Testis; Urea

1996
[Body fat loss in patients with Parkinson's disease].
    Rinsho shinkeigaku = Clinical neurology, 1997, Volume: 37, Issue:7

    Topics: Adipose Tissue; Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Body Weight; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1997
The antagonistic effects of L-dopa and eserine on Al-induced neurobehavioral deficits in rats.
    Biomedical and environmental sciences : BES, 1998, Volume: 11, Issue:4

    Topics: Aluminum; Animals; Body Weight; Cholinesterase Inhibitors; Dopamine Agents; Drug Evaluation, Preclinical; Female; Levodopa; Maze Learning; Memory; Neurotoxins; Physostigmine; Rats; Rats, Sprague-Dawley

1998
Effects of a seven-day continuous infusion of L-DOPA on daily rhythms in the rat.
    European journal of pharmacology, 2000, Jul-28, Volume: 401, Issue:1

    Topics: Analysis of Variance; Animals; Body Temperature; Body Weight; Circadian Rhythm; Dopamine Agents; Heart Rate; Infusions, Parenteral; Levodopa; Male; Motor Activity; Rats; Rats, Wistar; Time Factors

2000
GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
    The European journal of neuroscience, 2001, Volume: 13, Issue:3

    Topics: Animals; Antiparkinson Agents; Body Weight; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Levodopa; Locomotion; Male; Mazindol; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Protein Precursors; Recovery of Function; RNA, Messenger; Substantia Nigra; Tachykinins; Tritium; Tyrosine 3-Monooxygenase

2001
[Effects of several catecholamine-related drugs on aggressive behavior, brain noradrenaline content and tyramine uptake by isolated mice].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1977, Volume: 73, Issue:1

    Topics: Aggression; Agonistic Behavior; Animals; Body Weight; Brain; Brain Chemistry; Ditiocarb; Dopamine; Drug Antagonism; Drug Synergism; Humans; In Vitro Techniques; Levodopa; Male; Mice; Norepinephrine; Reserpine; Social Isolation; Thiocarbamates; Tyramine

1977
The pharmacological and anatomical substrates of the amphetamine response in the rat.
    Brain research, 1975, Jan-17, Volume: 83, Issue:3

    Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Cerebral Cortex; Cocaine; Dextroamphetamine; Drinking Behavior; Feeding Behavior; Humans; Hydroxydopamines; Levodopa; Locomotion; Male; Neural Pathways; Norepinephrine; Rats; Receptors, Adrenergic; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra; Tyrosine 3-Monooxygenase

1975
Effects of L-dopa and L-5-hydroxytryptophan on locomotor activity of the rat after selective or combined destruction of central catecholamine and serotonin neurons.
    The Journal of pharmacology and experimental therapeutics, 1979, Volume: 211, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Body Weight; Catecholamines; Humans; Levodopa; Locomotion; Male; Neurons; Psychomotor Agitation; Rats; Serotonin; Stereotyped Behavior; Telencephalon

1979
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 48, Issue:1

    Topics: Adult; Aldosterone; Body Weight; Carbidopa; Edema; Female; Humans; Hydrazines; Levodopa; Metoclopramide; Renin; Sodium

1979
Effect of L-dopa on the ovary of aged hens.
    Poultry science, 1979, Volume: 58, Issue:6

    Topics: Aging; Animals; Body Weight; Chickens; Feathers; Female; Injections, Subcutaneous; Levodopa; Ovary; Oviducts; Ovulation

1979
Short- and long-term effects of a massive dose of 6-OH-DA upon marsh mice.
    Research communications in chemical pathology and pharmacology, 1977, Volume: 17, Issue:3

    Topics: Aggression; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Cannibalism; Female; Humans; Hydroxydopamines; Levodopa; Male; Maternal-Fetal Exchange; Mice; Neoplasms; Pregnancy; Time Factors

1977
[Comparative study of various growth-hormone-secretion stimulation tests in short patients].
    Revista clinica espanola, 1977, Dec-15, Volume: 147, Issue:5

    Topics: Adolescent; Animals; Arginine; Body Height; Body Weight; Child; Deficiency Diseases; Dwarfism, Pituitary; Growth Hormone; Humans; Insulin; Levodopa; Male; Stimulation, Chemical

1977
Effects of L-DOPA administration upon monoamine oxidase activity in rat tissues.
    Life sciences, 1978, Volume: 22, Issue:7

    Topics: Animals; Body Weight; Brain; Kidney; Levodopa; Liver; Male; Monoamine Oxidase; Myocardium; Organ Size; Rats; Substrate Specificity; Vas Deferens

1978
Weight loss in patients treated long-term with levodopa. Metabolic aspects.
    Journal of the neurological sciences, 1976, Volume: 30, Issue:1

    Topics: Age Factors; Aged; Body Weight; Fatty Acids; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease

1976
Levodopa, fertility, and longevity.
    Science (New York, N.Y.), 1977, Apr-29, Volume: 196, Issue:4289

    Topics: Animals; Birth Weight; Body Weight; Dose-Response Relationship, Drug; Female; Fertility; Hair; Levodopa; Litter Size; Longevity; Male; Mice; Motor Activity; Pregnancy; Pregnancy, Animal

1977
Toxicity of mild prenatal carbon monoxide exposure.
    Science (New York, N.Y.), 1977, Aug-12, Volume: 197, Issue:4304

    Topics: Animals; Animals, Newborn; Behavior, Animal; Birth Weight; Body Weight; Brain; Carbon Monoxide; Disease Models, Animal; Dopamine; Female; Fetus; Levodopa; Maternal-Fetal Exchange; Motor Activity; Nerve Tissue Proteins; Norepinephrine; Pregnancy; Rats; Smoking

1977
On spinal noradrenaline receptor supersensitivity: correlation between nerve terminal densities and flexor reflexes various times after intracisternal 6-hydroxydopamine.
    Brain research, 1976, Nov-12, Volume: 116, Issue:3

    Topics: Animals; Apomorphine; Body Weight; Cell Count; Clonidine; Dose-Response Relationship, Drug; Hindlimb; Hydroxydopamines; Levodopa; Male; Nerve Endings; Nialamide; Rats; Receptors, Adrenergic; Reflex; Serotonin; Spinal Cord; Time Factors

1976
Letter: Fattening of parkinsonians: a hypothalamic side effect of L-dopa?
    The Medical journal of Australia, 1975, Oct-11, Volume: 2, Issue:15

    Topics: Body Weight; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Stimulation, Chemical

1975
The effects of daily injections of L-dihydroxyphenylalanine and 5-hydroxytryptophan in different temporal relationships on thyroid-gonadal interaction in an Indian finch, spotted munia, Lonchura punctulata.
    General and comparative endocrinology, 1992, Volume: 86, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Birds; Body Weight; Female; Levodopa; Light; Male; Sexual Behavior, Animal; Testis; Thyroid Gland; Thyroidectomy; Thyroxine

1992
Hereditary progressive dystonia with diurnal fluctuation (Segawa's syndrome)--an unusual case.
    Neuropediatrics, 1992, Volume: 23, Issue:5

    Topics: Body Weight; Child; Chromosomes, Human, Pair 9; Circadian Rhythm; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Muscle Tonus; Neurologic Examination

1992
Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients.
    The American journal of clinical nutrition, 1992, Volume: 55, Issue:3

    Topics: Aged; Body Weight; Dietary Proteins; Energy Intake; Female; Humans; Levodopa; Male; Middle Aged; Nutritional Status; Parkinson Disease; Prealbumin; Serum Albumin; Surveys and Questionnaires

1992
Growth screening. A positive medical experience.
    Clinical pediatrics, 1992, Volume: 31, Issue:8

    Topics: Adolescent; Arginine; Arkansas; Body Height; Body Weight; Child; Child, Preschool; Community Health Services; Exercise; Female; Growth Disorders; Growth Hormone; Hospitals, Pediatric; Humans; Infant; Insulin; Levodopa; Male; Mass Screening; Outpatient Clinics, Hospital

1992
A new motor test sensitive to aging and dopaminergic function.
    Journal of neuroscience methods, 1991, Volume: 39, Issue:2

    Topics: Aging; Animals; Body Weight; Dextroamphetamine; Dopamine; Haloperidol; Levodopa; Male; Motor Activity; Neuropsychological Tests; Rats; Rats, Inbred Strains

1991
The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Neuroscience, 1991, Volume: 40, Issue:2

    Topics: Animals; Apomorphine; Body Weight; Carbidopa; Corpus Striatum; Drinking; Female; Fetal Tissue Transplantation; Hydroxydopamines; Levodopa; Mesencephalon; Motor Activity; Nervous System; Oxidopamine; Parkinson Disease; Rats; Rotation; Stereotyped Behavior; Time Factors

1991
Effects of high salt intake on dopamine production in rat kidney.
    The American journal of physiology, 1991, Volume: 260, Issue:5 Pt 1

    Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Body Weight; Carbidopa; Denervation; Dopamine; Inulin; Kidney; Levodopa; Male; Rats; Rats, Inbred Strains; Reference Values; Sodium, Dietary

1991
Effects of dietary tyrosine on L-dopa- and amphetamine-induced changes in locomotor activity and neurochemistry in mice.
    Pharmacology, biochemistry, and behavior, 1990, Volume: 37, Issue:2

    Topics: Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Dextroamphetamine; Diet; Drug Interactions; Levodopa; Male; Mice; Motor Activity; Phenylalanine; Tyrosine

1990
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Metabolism: clinical and experimental, 1990, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Arginine; Body Weight; Diet, Reducing; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Obesity; Weight Loss

1990
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.
    Brain research, 1990, Oct-01, Volume: 528, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Body Weight; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrazines; Levodopa; Male; Methyltyrosines; Mice; Mice, Inbred C57BL; Motor Activity; Parkinson Disease, Secondary; Receptors, Dopamine; Stereotyped Behavior

1990
Influence of estrogen administration on growth hormone response to GHRH and L-Dopa in patients with Turner's syndrome.
    Acta endocrinologica, 1989, Volume: 120, Issue:4

    Topics: Adolescent; Body Weight; Ethinyl Estradiol; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Peptide Fragments; Turner Syndrome

1989
Practical application of a low-protein diet for Parkinson's disease.
    Neurology, 1988, Volume: 38, Issue:7

    Topics: Body Weight; Dietary Proteins; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Serum Albumin

1988
L-dopa metabolism in genetically hypertensive mice: effect of pargyline.
    Canadian journal of physiology and pharmacology, 1987, Volume: 65, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Dopamine; Dopamine beta-Hydroxylase; Drug Interactions; Hypertension; Levodopa; Mice; Norepinephrine; Normetanephrine; Pargyline

1987
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
    Experimental and clinical endocrinology, 1986, Volume: 88, Issue:3

    Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; Propranolol; Somatomedins

1986
Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa.
    Behavioral neuroscience, 1985, Volume: 99, Issue:3

    Topics: Animals; Behavior, Animal; Body Weight; Brain Mapping; Dopamine; Drinking Behavior; Feeding Behavior; Hydroxydopamines; Levodopa; Limbic System; Male; Mesencephalon; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains

1985
Letter: Treatment of anorexia nervosa by levodopa.
    Lancet (London, England), 1974, Sep-07, Volume: 2, Issue:7880

    Topics: Adolescent; Adult; Alopecia; Anorexia Nervosa; Blood Cell Count; Body Weight; Female; Humans; Levodopa

1974